𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

✍ Scribed by Lesley M. Arnold; Amy Rosen; Yili Lu Pritchett; Deborah N. D'Souza; David J. Goldstein; Smriti Iyengar; Joachim F. Wernicke


Book ID
116817689
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
265 KB
Volume
119
Category
Article
ISSN
0304-3959

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A double-blind, multicenter trial compar
✍ Lesley M. Arnold; Yili Lu; Leslie J. Crofford; Madelaine Wohlreich; Michael J. D πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

## Abstract ## Objective To assess the efficacy and safety of duloxetine, a serotonin and norepinephrine reuptake inhibitor, in subjects with primary fibromyalgia, with or without current major depressive disorder. ## Methods This study was a randomized, double‐blind, placebo‐controlled trial co

Gabapentin in the treatment of fibromyal
✍ Lesley M. Arnold; Don L. Goldenberg; Sharon B. Stanford; Justine K. Lalonde; H. πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 168 KB πŸ‘ 3 views

## Abstract ## Objective To assess the efficacy and safety of gabapentin in patients with fibromyalgia. ## Methods A 12‐week, randomized, double‐blind study was designed to compare gabapentin (1,200–2,400 mg/day) (n = 75 patients) with placebo (n = 75 patients) for efficacy and safety in treatin